Cat No : RP10243X. Detection of COVID-19 specific target genes in a single tube- Reliable result with three target genes- Results within 1 hour and 50 minutes after extraction- Convenient work now on the automated MDx platform- Suitable for high-throughput- Providing whole process control for assay validity- Automated data interpretation with Seegene Viewer.
Cat No : 11NCo10. SD biosensor STANDARD M nCoV Real-Time Detection kit is used for identification and detectionof novel coronavirus (2019-nCoV) ORF1ab (RdRp) gene and E gene in humannasopharyngeal swab, oropharyngeal swab, and sputum specimens using reversetranscription (RT) real-time PCR. This kit is helpful for the auxiliary diagnosis of 2019novel coronavirus disease (COVID-19). The test results are for clinical referenceonly and cannot be used as a basis for confirming or excluding cases alone.
CAT No : R0160C. The OnSite Typhoid IgG/IgM Combo Rapid Test is a lateral flow immunoassay for the detection and differentiation of IgG and IgM anti-Salmonella typhi (S. typhi) and paratyphi in human serum, plasma or whole blood.
Product Description
Utilizes O Antigen And H Antigen From Both Typhi And Paratyphi Serovars To Maximize Sensitivity
Differentiates Between Igg And Igm To Determine Stage Of Infection
One Step Procedure Minimizes Operator Error Due To Sample Preparation
High Level Of Reproducibility
Test Kits Can Be Used And Stored In A Wide Range Of Temperatures
Rapid immuno-diagnosis of influenza A, B & SARS-CoV Single test for 3 parameters: antigen test of influenza A,B & SARS-CoV-2 Easy to use, Simple Procedure, Quick resulting and high Accuracy.
Production information:
1.Specimen: nasopharyngeal swab or Viral transport medium (VTM)
2.No Cross-reaction with 27 kinds of other respiratory viruses.
3.No interference with 23 kinds of interfering substances.
4.Limit of detection (LoD):1.89x10 HA units/mL for influenza A, 4.1 x 10 HA units/ mL for influenza B, 1.78x10 TCID/mL for SARS-CoV-2.
5.Detection of SARS-CoV-2 Varients: alpha,beta,gamma, delta, omicron & stealth omicron.
Rapid Antigen Test Card
Self-test received notified body approved CE marking on Apr.1,2021
A home test for the rapid qualitative detection of antigen in anterior nasal swabs within 7days of symptom onset
â?¢Sample type: nasal swab
â?¢Time to result: 15-20 min
â?¢Sensitivity: 96.77%Specificity: 99.20%Accuracy: 98.72%
â?¢Layperson study statistics:
99.10% of non-professionals carried out the test without requiring
97.87% of different types of results were interpreted correctly
Each Test have Unique Identifier Number - Easy to track
Approved By - UK, Germany, France, Spain, Netherlands, Greece, Belgium, Italy, Portugal.
1 Test / Kit
Catalog No.: 1N40C5-2
Kit Components:
1 Rapid SARS-CoV-2
Antigen Test Card (sealed
foil pouch)
1 sterilized swab
1 extraction tube
1 sample extraction buffer
IFU
Tube holder on back of box
Box / Carton Specifications :
1 Test / Kit
Box size - 190*60*15 mm
Carton size - 42*42*33 cm
250 tests (boxes) / carton
Carton gross weight - 9.9 kg
Price and Minumum Quantity
Price FOB in USD: -Minimum Order Qty: 2000 Pieces
Production Capacity: 10 Million Units A MonthPackaging: Pack Of 1, 5, 20
Product Model And Origin: Xiamen China
Brand: BOSON
For the newly discovered new coronavirus mutant strain Omicron(B.1.1.529),our conducts the sequence comparison analysis of its 32 mutation sites. All mutation sites are outside the epitope region recognized by the new crown paired monoclonal antibody selected by our company.Therefore,according to known academic opinions,the effective production strain for Omicron(B.1.1.529)can still be detected by our product"SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)"
Next,our will continue to follow up on the mutation of Covid-19perform sequence alignment analysis in timeand evaluate and verify the detection ability of key mutation sites to ensure the sensitivity and specificity of the kit.
The 2019-nCoV Ag Saliva Rapid Test is a lateral flow immunoassav intended for the qualitative detection of nucleocapsid protein antigen from2019-nCoV in saliva specimens directly collected from individuals who are suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset
PO from Buyer
CI from Seller
Buyer signs and returns the CI
Seller's Attorney prepared LOA and submits to Buyer
Escrow Agreement from Seller is signed
Buyer escrows funds for full purchase
SGS inspection is performed at buyer's expense
Logistics details are exchanged
Upon confirmed report, escrowed funds are released simultaneous with title transfer
